Endovascular Access

The Percutek Thoracic Stent Graft System is designed to deliver reliable sealing, excellent conformability, and long-term clinical performance in the endovascular treatment of thoracic aortic pathologies. Its advanced stent architecture, combined with a low-profile delivery system, enables precise placement, controlled deployment, and adaptability to challenging anatomies.


Durable Seal and Superior Conformability

• Dual short-strutted proximal stents (5 mm and 7.5 mm) provide secure sealing and excellent circumferential conformability.
• Nitinol alloy construction ensures an optimal balance between strong radial force and high flexibility.
• Multiple stent heights (5 mm, 7.5 mm, 12 mm, and 15 mm) distributed along the graft enhance overall flexibility and anatomical adaptability.
• Increased distal stent height helps reduce mechanical stress while improving sealing performance and graft conformability.
• Designed to achieve low type I endoleak rates and durable long-term patency.

Smooth Delivery and Controlled Deployment

• A kink-resistant, low-profile delivery system (18Fr for stent grafts ≤28 mm) enables smooth and reliable navigation through the vasculature.
• Full hydrophilic coating further facilitates easy advancement and controlled handling.
• Post-release deployment mechanism ensures precise and predictable stent graft release.
• Adjustable repositioning capability is maintained even after deployment of up to three stents.

Broad Anatomical Coverage and Versatility

• Specifically designed for the treatment of thoracic aortic aneurysms and dissections.
• Extensive size matrix offers exceptional procedural flexibility, including graft lengths up to 240 mm and tapers of up to 10 mm.
• The dual short-strut proximal stent design allows excellent conformability and supports a minimal proximal landing zone requirement of 10 mm.
• Suitable for a wide range of challenging anatomical conditions.

Clinical Indications

The Percutek Thoracic Stent Graft System is indicated for endovascular treatment of diseases of the descending thoracic aorta, including but not limited to aneurysms and dissections, in patients who meet the following criteria:

• Adequate iliac and/or femoral access
• Descending thoracic aortic pathology with a proximal neck diameter between 20 and 44 mm
• Proximal landing zone length of at least 10 mm, without significant calcification and/or thrombosis
• Anatomical morphology suitable for endovascular repair